ALDEA Pharmaceuticals, Inc. — Form D/A
ALDEA Pharmaceuticals, Inc. of REDWOOD CITY, CA, a company, filed a Form D amendment with the SEC on 2013-11-18. The offering totals $11.5M, of which $11.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-11-18
- Form: D/A
- Accession: 0001531984-13-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $11.5M
- Amount sold: $11.4M
- Remaining: $103K
- Investors: 6
- Date of first sale: 2011-09-23
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-166855
Issuer
- Name: ALDEA Pharmaceuticals, Inc.
- CIK: 0001531984
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 3696 HAVEN AVE., SUITE C, REDWOOD CITY, CA, 94063
- Phone: 650 241-1600
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Timothy Shannon | Director | Stamford, CT |
| Timothy Shannon | Executive Officer | Stamford, CT |
| EVGENY ZAYTSEV | Director | SAN FRANCISCO, CA |
| John Walker | Director | Birmingham, AL |
| Wende Hutton | Director | Menlo Park, CA |
| Howard Rosen | Director | Woburn, MA |
| William Yelle | Director | MORRISVILLE, NC |
| William Yelle | Executive Officer | MORRISVILLE, NC |
| Richard Shames, M.D. | Executive Officer | Redwood City, CA |
| Wenjin Yang | Executive Officer | Redwood City, CA |
| Vernon Jiang, Ph.D. | Executive Officer | Redwood City, CA |
| Daria Mochly-Rosen | Director | Palo Alto, CA |
Other filings by this issuer (4)
More